Eye-Movement Desensitization and Reprocessing in the ED and Post-Traumatic Syndrome (NCT03194386) | Clinical Trial Compass
CompletedNot Applicable
Eye-Movement Desensitization and Reprocessing in the ED and Post-Traumatic Syndrome
France110 participantsStarted 2016-10
Plain-language summary
Millions people, all over the world, are admitted in the Emergency Department after a trauma or simply to receive medical cares. In France, it represents 10 million patients. Probably because of stress associated with the event, 20% will suffer a combination of non-specifics symptoms which persist for many months and with daily life quality impairment. The investigators hypothesize that an early intervention, such as Eye-Movement, Desensitization and Reprocessing (EMDR) could be performed in the ED and could prevent the occurrence of these symptoms
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients admitted in department for a medical or traumatic event, and at risk of developing a PTS.
* Score resulting from the screening tool\> 3 :
Female gender: +1 Taking at least one anxiolytic treatment: + 1 Perceived health status prior to admission: Excellent, very good: 0 ; Good: +1 Poor: +2 ; Bad: +3
* Affiliated to Social Security
Exclusion Criteria:
* Refusal to participate in the study
* Admission and / or exit questionnaire not completed
* Inability to answer questionnaire: any cognitive impairement, language barrier, consciousness disorder...
* Impossibility of recontacting the patient at a distance from the trauma (no telephone contact ...)
* Patient already included in the study.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial tested whether a single EMDR session could be completed right in the emergency department — is that approach considered safe and realistic for someone in my situation, or is it better to wait until I'm more stabilized before starting trauma therapy?
2Since this trial has already been completed, has my doctor seen the results, and what do those findings suggest about whether early EMDR in an emergency setting actually reduces the risk of developing full PTSD compared to waiting for outpatient care?
3EMDR is a specific type of eye-movement therapy — how does it compare to other PTSD treatments I might qualify for now, like cognitive processing therapy or medication, and would my doctor recommend it as a first step?
4Because this was listed as Phase NA, meaning it was more of a feasibility or procedural study than a full efficacy trial, does that mean there's still limited evidence about whether this approach truly works long-term, and should I look for a more advanced trial or standard treatment instead?
5If I'm interested in EMDR therapy for PTSD prevention after a traumatic event, are there currently open trials or established clinical programs my doctor could refer me to, given that this particular study is already closed to enrollment?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.